Cisplatin, Cyclophosphamide, Methotrexate, and 5-Fluorouracil (Pcmf) as First Line Therapy of Metastatic Triple Negative Breast Cancer (Mtnbc) in Patients Previously Treated with Adjuvant Anthracyclines and Taxanes: Retrospective Analysis

Donat, Dragutin A

Rezultati

eNauka > Rezultati > Cisplatin, Cyclophosphamide, Methotrexate, and 5-Fluorouracil (Pcmf) as First Line Therapy of Metastatic Triple Negative Breast Cancer (Mtnbc) in Patients Previously Treated with Adjuvant Anthracyclines and Taxanes: Retrospective Analysis

Naziv:	Cisplatin, Cyclophosphamide, Methotrexate, and 5-Fluorouracil (Pcmf) as First Line Therapy of Metastatic Triple Negative Breast Cancer (Mtnbc) in Patients Previously Treated with Adjuvant Anthracyclines and Taxanes: Retrospective Analysis
Autori:	Donat, Dragutin A
Godina:	2012
Publikacija:	ANNALS OF ONCOLOGY
ISSN:	0923-7534 Annals of Oncology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 23 str. 137-138
WoS-ID:	000309409000384
URI:	https://enauka.gov.rs/handle/123456789/819825
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.